Raquel Rogers

1.1k total citations · 1 hit paper
11 papers, 725 citations indexed

About

Raquel Rogers is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Raquel Rogers has authored 11 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Raquel Rogers's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (4 papers) and Biosimilars and Bioanalytical Methods (2 papers). Raquel Rogers is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (4 papers) and Biosimilars and Bioanalytical Methods (2 papers). Raquel Rogers collaborates with scholars based in United States, Italy and France. Raquel Rogers's co-authors include Silvio Danese, Edward V. Loftus, Bruce E. Sands, Richard A. Lirio, Stefan Schreiber, Laurent Peyrin‐Biroulet, Jeffrey D. Bornstein, Jingjing Chen, Brihad Abhyankar and Jean–Frédéric Colombel and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Raquel Rogers

11 papers receiving 718 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

2019 461 citations Bruce E. Sands, Laurent Peyrin‐Biroulet et al. New England Journal of Medicine profile →

Peers

Raquel Rogers

GENET

EPIDE

SURGE

IMMUN

GASTR

Francisco Fidencio Cons Molina Colombia

Veerle J. Nuij Netherlands

Gregor Novak Slovenia

Patricia K. Heath United Kingdom

Francesca Bredin United Kingdom

Polymnia Galiatsatos Canada

Alexander Eser Austria

S. Willot France

Kathleen M. Schieffer United States

Panu Wetwittayakhlang Thailand

Francisco Fidencio Cons Molina Colombia

Raquel Rogers

283 ×0.5

GENET

235 ×0.5

EPIDE

95 ×0.5

SURGE

120 ×0.8

IMMUN

22 ×0.3

GASTR

Citations per year, relative to Raquel Rogers Raquel Rogers (= 1×) peers Francisco Fidencio Cons Molina

Countries citing papers authored by Raquel Rogers

Since Specialization

Citations

This map shows the geographic impact of Raquel Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Rogers more than expected).

Fields of papers citing papers by Raquel Rogers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquel Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Rogers. The network helps show where Raquel Rogers may publish in the future.

Co-authorship network of co-authors of Raquel Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of Raquel Rogers. A scholar is included among the top collaborators of Raquel Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquel Rogers. Raquel Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Dauvilliers, Yves, Emmanuel Mignot, Rafael del Río Villegas, et al.. (2023). Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1. New England Journal of Medicine. 389(4). 309–321. 41 indexed citations

Peyrin‐Biroulet, Laurent, Edward V. Loftus, Jean‐Frédéric Colombel, et al.. (2021). Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY). Gastroenterology. 161(4). 1156–1167.e3. 32 indexed citations

Loftus, Edward V., Brian G. Feagan, Remo Panaccione, et al.. (2020). Long‐term safety of vedolizumab for inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 52(8). 1353–1365. 119 indexed citations

Sands, Bruce E., Laurent Peyrin‐Biroulet, Edward V. Loftus, et al.. (2019). Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. New England Journal of Medicine. 381(13). 1215–1226. 461 indexed citations breakdown →

Schreiber, Stefan, Laurent Peyrin‐Biroulet, Edward V. Loftus, et al.. (2019). OP34 VARSITY: A double-blind, double-dummy, randomised, controlled trial of vedolizumab versus adalimumab in patients with active ulcerative colitis. Journal of Crohn s and Colitis. 13(Supplement_1). S612–S613. 18 indexed citations

Sands, Bruce E., Laurent Peyrin‐Biroulet, Edward V. Loftus, et al.. (2019). 416a – Vedolizumab Shows Superior Efficacy Versus Adalimumab: Results of Varsity—The First Head-To-Head Study of Biologic Therapy for Moderate-To-Severe Ulcerative Colitis. Gastroenterology. 156(6). S–81. 6 indexed citations

Ciccocioppo, Rachele, Catherine Klersy, Daniel A. Leffler, et al.. (2019). Systematic review with meta‐analysis: Safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas. JGH Open. 3(3). 249–260. 33 indexed citations

Loftus, Edward V., Jean‐Frédéric Colombel, Brian G. Feagan, et al.. (2019). 835 – Long-Term Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease: Final Results from the Gemini Lts Study. Gastroenterology. 156(6). S–182. 2 indexed citations

Vermeire, Séverine, J F Colombel, Brian G. Feagan, et al.. (2019). OP26 Long-term safety of vedolizumab in ulcerative colitis and Crohn’s disease: final results from the GEMINI LTS study. Journal of Crohn s and Colitis. 13(Supplement_1). S018–S020. 11 indexed citations

10.

Ciccocioppo, Rachele, Catherine Klersy, Daniel A. Leffler, et al.. (2018). P681 Systematic review and meta-analysis of the safety and efficacy of intra-fistular injections of mesenchymal stem cells in clinical trials and observational cohort studies. Journal of Crohn s and Colitis. 12(supplement_1). S455–S456. 1 indexed citations

11.

Ciccocioppo, Rachele, et al.. (2018). Mo1653 - Safety and Efficacy of Local Injections of Mesenchymal Stem Cells in Perianal Fistula in Crohn's Disease: A Systematic Review and Meta-Analysis of the Clinical Trials and Observational Cohort Studies. Gastroenterology. 154(6). S–784. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact